Abbott Plans to Acquire Bigfoot Biomedical, Growing Diabetes Portfolio
- Last week, Abbott announced plans to acquire Bigfoot Biomedical in the third quarter of 2023. If successful, this acquisition could significantly enhance Abbott’s diabetes management portfolio, adding new technology-driven tools to its repertoire. According to Abbott’s press release, Bigfoot Biomedical is a medical technology startup...